ETFs positioned on GSK plc

Name YTD change Weight AuM
+12.29% - 24,432 M€
+13.60% - 750 M€
-.--% - 22 M€
+12.44% - 44 M€
+1.72% - 49 M€
+0.74% - 51 M€
+11.71% - 66 M€
+8.20% - 75 M€
+5.32% - 6,576 M€
+6.00% - 274 M€
+10.50% - 122 M€
+4.66% - 1,193 M€
+9.79% - 1,674 M€
+8.16%9.81% 28 M€
+4.57%8.02% 9 M€
+9.58%7.14% 987 M€
-.--%7.14% 987 M€
+9.20%6.59% 12 M€
+12.75%5.94% 1,024 M€
+14.41%5.9% 38 M€
+8.41%5.9% 90 M€
+6.18%5.86% 56 M€
-1.24%5.75% 12 M€
+10.32%5.75% 820 M€
+5.13%5.14% 58 M€
+7.12%5.09% 11 M€
+13.35%5.09% 667 M€
+13.48%5.02% 19 M€
+7.64%4.94% 9 M€
+7.92%4.92% 1,018 M€
0.00%4.18% 8 M€
+61.55%4.1% 215 M€
+11.35%4.03% 1,807 M€
+10.40%3.8% 2,529 M€
+11.45%3.62% 50 M€
+6.84%3.57% 106 M€
+5.80%3.57% 19 M€
+6.20%3.57% 147 M€
+11.02%3.57% 1,166 M€
+7.70%3.48% 935 M€
+7.14%3.36% 1,190 M€
-.--%3.36% 1,190 M€
+15.35%3.33% 114 M€
+11.66%3.33% 265 M€
+10.23%3.31% 1,211 M€
Logo GSK plc
GSK plc is the world's No. 2 pharmaceutical group. Net sales break down by family of products as follows: - pharmaceutical products (41.3%): intended mainly for HIV infection (57% of net sales), immune system disorders and respiratory diseases (28.3%), and cancer (14.7%); - OTC and parapharmaceutical medicine (30.7%); - vaccines (28%). Net sales are distributed geographically as follows: the United Kingdom (2.1%), Europe (21%), the United States (51.6%), and other (25.3%).
Employees
66,841